An evidence-based look at what early research does, and does not, suggest about GLP-1 therapy such as semaglutide for methamphetamine use disorder.
An evidence-based look at what current research does, and does not, show about GLP-1 medications such as semaglutide for cocaine use disorder.
Somatic Experiencing treats trauma and addiction through the body, calming a dysregulated nervous system so cravings and triggers lose their grip. Here is how it works and where it fits.
EMDR therapy helps people with co-occurring trauma and addiction by reprocessing the memories that drive cravings, lowering the emotional charge behind triggers and reducing relapse risk.
Addiction is not a failure of willpower. Learn how repeated substance use rewires the brain's reward, habit, and control circuits, and how treatment uses that same plasticity to rebuild control.
Why GLP-1 Alone Is Not Enough for Addiction Recovery Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Is a GLP-1 medication alone sufficient for lasting addiction recovery? While GLP-1 receptor agonists like semaglutide effectively...
How GLP-1 Drugs Affect Dopamine and Reward Pathways Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment How do GLP-1 receptor agonists suppress substance cravings in the brain? Research reveals that these medications reach deep...
The Future of GLP-1 Medications in Addiction Medicine Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment What is the future of GLP-1 medications in addiction medicine? While drugs like semaglutide and tirzepatide are currently...
GLP-1 and Nicotine Addiction: Can Semaglutide Help You Quit? Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 receptor agonists like semaglutide help you quit smoking? While traditionally prescribed for type 2 diabetes...
Can GLP-1 Medications Help Reduce Opioid Cravings? Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 medications help reduce opioid cravings? Recent clinical studies and real-world population data indicate that GLP-1 receptor agonists,...